Commission Regulation (EU) 2023/699 of 29 March 2023 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2023
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act included in a Joint Committee Decision (JCD); entry into force of the Decision is pending Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Legal documents
Commission Regulation (EU) 2023/699 of 29 March 2023 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate with effect from 1 April 2023
VERORDNUNGEN VERORDNUNG (EU) 2023/699 DER KOMMISSION vom 29. März 2023zur Änderung der Verordnung (EG) Nr. 297/95 des Rates zwecks Anpassung der Gebühren der Europäischen Arzneimittel-Agentur an die Inflationsrate mit Wirkung vom 1. April 2023
History
23.09.2023
Adopted JCD confirmed entry into force date
23.09.2023
Compliance date in the EEA
22.09.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
07.06.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
29.03.2023
Adoption date in the EU
01.04.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.